Growing literature has indicated that dysregulation of TUG1 is involved in lung-related diseases, such as chronic obstructive pulmonary disease (COPD) (13), pneumonia (14), and pulmonary arterial hypertension (PAH) (15). Here, TUG1 is linked to pulmonary arterial hypertension.